Addus HomeCare (ADUS) Projected to Post Earnings on Monday

Key Points

• Addus HomeCare is expected to announce its Q2 2025 earnings on August 4th, with analysts projecting earnings of $1.45 per share and revenue of $345.71 million.
• The company reported a net margin of 6.52% and a return on equity of 9.23% in its last earnings report, with a year-over-year revenue increase of 20.3%.
• Analysts have a favorable outlook on the stock, with seven buy ratings and a target price averaging $142.57, while institutional investors hold 95.35% of the stock.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) is expected to post its Q2 2025 quarterly earnings results after the market closes on Monday, August 4th. Analysts expect Addus HomeCare to post earnings of $1.45 per share and revenue of $345.71 million for the quarter.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. The business had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. Addus HomeCare's quarterly revenue was up 20.3% on a year-over-year basis. During the same period last year, the firm posted $1.21 earnings per share. On average, analysts expect Addus HomeCare to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Price Performance

ADUS traded down $0.24 on Thursday, reaching $107.64. The company had a trading volume of 60,277 shares, compared to its average volume of 188,357. The business has a 50 day simple moving average of $112.14 and a 200 day simple moving average of $109.08. The company has a market cap of $1.98 billion, a price-to-earnings ratio of 24.31, a P/E/G ratio of 1.53 and a beta of 0.81. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $136.72.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ADUS shares. JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research note on Wednesday, July 16th. Macquarie reissued an "outperform" rating and set a $133.00 price target on shares of Addus HomeCare in a research note on Tuesday, June 10th. Finally, Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $142.57.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the transaction, the executive vice president owned 7,796 shares of the company's stock, valued at approximately $896,540. The trade was a 20.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently made changes to their positions in ADUS. Royal Bank of Canada increased its position in shares of Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company's stock valued at $682,000 after purchasing an additional 1,347 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company's stock valued at $1,026,000 after acquiring an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Addus HomeCare by 6.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company's stock valued at $5,111,000 after acquiring an additional 2,952 shares during the period. Jane Street Group LLC boosted its stake in Addus HomeCare by 387.6% in the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company's stock worth $1,092,000 after purchasing an additional 8,780 shares during the period. Finally, Intech Investment Management LLC boosted its position in shares of Addus HomeCare by 44.7% during the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company's stock valued at $1,420,000 after acquiring an additional 4,439 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.